As part of the Healthy Longevity Global Competition, the U.S. National Academy of Medicine (“NAM”), with support from Johnson & Johnson Innovation, will issue up to 24 Catalyst Awards per year, in three annual rounds (i.e., in 2020, 2021, and 2022). Each Catalyst Award includes a $50,000 cash prize as well as travel costs to attend an annual Innovator Summit.
PCF seeks applications from the global biomedical research community. Applicants traditionally under-represented in science and medicine are highly encouraged. The Foundation seeks applications from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of prostate cancer.
The Pew Scholars Program in the Biomedical Sciences provides funding to young investigators of outstanding promise in science relevant to the advancement of human health. The program makes grants to selected academic institutions to support the independent research of outstanding individuals who are in their first few years of their appointment at the assistant professor level.
Johnson & Johnson Vision is committed to supporting education and activities that further the advancement of the profession and patient care. Find out if one if these opportunities is right for you.
- Fellowship & Scholarship Grants: J&J is dedicated to providing educational opportunities and support for activities that are intended to improve patient care.
- Educational Grants: Do you believe that education is important to your success? Interested in funding for continuing education? Visit J&J's Educational Grants section to learn more.
- Investigator-Initiated Studies: J&J is always looking for ways to support independent individuals with their research. J&J is currently ONLY accepting applications for Johnson & Johnson Surgical Vision (IOLs, refractive surgery, ocular surface disease, etc.). No Johnson & Johnson Vision Care (contact lenses, contact lens care products, and eye drops) applications are being accepted at this time.
Lilly Grant Office—Healthcare professional education/Patient advocacy and Consumer education programs
As a commitment to improving patient care and providing valuable information to the medical and broader healthcare community, Lilly will accept the following grant requests:
- Healthcare professional education (priority will be given to accredited programs)
- Patient advocacy and Consumer education programs (e.g., disease-state education and awareness, screenings, etc.)
Funding may be requested in the form of support for an educational program, scientific awards, select fellowships, or charitable contributions. Lilly does not provide unrestricted grants or grants to individuals or
The focus of the Lilly Grant Office (LGO) will be on healthcare-related CME/CE programs as well as patient education and advocacy in the following therapeutic areas:
- Neuroscience - Migraine and Headache Disorders
- Chronic pain associated with osteoarthritis and chronic low back pain
Boston Scientific provides support for research that advances medical and scientific knowledge about our products and that generates medical interventions.
Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future. RWJF is interested in ideas that address any of these four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work. Additionally, RWJF welcomes ideas that might fall outside of these four focus areas, but which offer unique approaches to advancing health equity and our progress toward a Culture of Health.
Ginkgo has built their platform to enable partners across a wide range of applications to rapidly scale their R&D efforts, and they want to apply this technology today to the fight against the pandemic. To support the people building the treatments that will stop COVID-19 Ginkgo is now offering:
These awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.
The COVID-19 High Performance Computing (HPC) Consortium is a unique private-public effort spearheaded by the White House Office of Science and Technology Policy, the U.S. Department of Energy and IBM to bring together federal government, industry, and academic leaders who are volunteering free compute time and resources on their world-class machines.